CCEP vs NOMD
Coca-cola Europacific Partners PLC and Nomad Foods Ltd., side by side — 10 fiscal years reported in EUR, drawn from SEC filings.
Most recent reported year
| Metric | CCEP | NOMD |
|---|---|---|
| Revenue | €20.9B | €3.0B |
| Net income | €1.9B | €136.7M |
| Gross margin | 35.6% | 27.1% |
| Net margin | 9.5% | 4.5% |
| Return on equity | 23.8% | 5.3% |
| Diluted EPS | €4.26 | €0.91 |
| Dividend / share | · | $0.68 |
| Payout ratio | 47.5% | 66.8% |
| Free cash flow | €2.2B | €252.2M |
| Equity | €7.8B | · |
| Net debt / equity | · | · |
| Current ratio | 0.80× | 1.07× |
| Revenue CAGR 5y | 14.5% | 3.8% |
| Profit CAGR 5y | 31.3% | −9.5% |
CCEP bills 6.9× the revenue of NOMD, and keeps more of each dollar of revenue as profit (9.5% against 4.5%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | CCEP | NOMD |
|---|---|---|
| FY2025 | €20.9B | €3.0B |
| FY2024 | €20.4B | €3.1B |
| FY2023 | €18.3B | €3.0B |
| FY2022 | €17.3B | €2.9B |
| FY2021 | €13.8B | €2.6B |
| FY2020 | €10.6B | €2.5B |
| FY2019 | €12.0B | €2.3B |
| FY2018 | €11.5B | €2.2B |
| FY2017 | €11.1B | €2.0B |
| FY2016 | €9.1B | €1.9B |
Bottom line
| Fiscal year | CCEP | NOMD |
|---|---|---|
| FY2025 | €1.9B | €136.7M |
| FY2024 | €1.4B | €227.1M |
| FY2023 | €1.7B | €192.7M |
| FY2022 | €1.5B | €249.8M |
| FY2021 | €982.0M | €181.0M |
| FY2020 | €498.0M | €225.2M |
| FY2019 | €1.1B | €154.0M |
| FY2018 | €909.0M | €171.2M |
| FY2017 | €688.0M | €136.5M |
| FY2016 | €549.0M | €36.4M |
10 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +€17,868,500,000 | CCEP |
| FY2024 | +€17,338,200,000 | CCEP |
| FY2023 | +€15,257,500,000 | CCEP |
| FY2022 | +€14,380,300,000 | CCEP |
| FY2021 | +€11,156,400,000 | CCEP |
| FY2020 | +€8,090,100,000 | CCEP |
| FY2019 | +€9,692,700,000 | CCEP |
| FY2018 | +€9,345,200,000 | CCEP |
| FY2017 | +€9,105,400,000 | CCEP |
| FY2016 | +€7,205,300,000 | CCEP |
CCEP has reported the higher revenue in every one of these 10 fiscal years. The gap has widened since the earliest year compared.
10 of 12 comparable fiscal years — a year missing data on either side is not counted.
10 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +5.0 pp | CCEP |
| FY2024 | −0.3 pp | NOMD |
| FY2023 | +2.8 pp | CCEP |
| FY2022 | +0.3 pp | CCEP |
| FY2021 | +0.2 pp | CCEP |
| FY2020 | −4.3 pp | NOMD |
| FY2019 | +2.5 pp | CCEP |
| FY2018 | +0.0 pp | CCEP |
| FY2017 | −0.8 pp | NOMD |
| FY2016 | +4.1 pp | CCEP |
The higher net margin has changed hands between CCEP and NOMD over this period.
10 of 11 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
NOMD's net margin has been more volatile than CCEP's over the 10 comparable fiscal years — 2.0 percentage points of standard deviation against 1.5.
10 of 11 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between CCEP and NOMD over these 10 fiscal years — CCEP led in 7 and NOMD in 3.
10 of 11 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
CCEP's return on equity has been more volatile than NOMD's over the 10 comparable fiscal years — 4.7 percentage points of standard deviation against 2.3.
10 of 12 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between CCEP and NOMD over these 10 fiscal years — CCEP led in 9 and NOMD in 1.
10 of 12 comparable fiscal years — a year missing data on either side is not counted.